October 31st, 2009
The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke.
Posted in Uncategorized | Comments Off
October 30th, 2009
Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries.
Posted in Uncategorized | Comments Off
October 30th, 2009
Ultrasound is said to heal chronic wounds that don't respond to other treatments.
Posted in Uncategorized | Comments Off
October 28th, 2009
Company pulls application for a promising experimental drug.
Posted in Uncategorized | Comments Off
October 27th, 2009
Study finds troubling weight gains in children taking brand-name psychiatric drugs.
Posted in Uncategorized | Comments Off